Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Myint Aung Win"'
Publikováno v:
Journal of Enterprise Information Management, 2013, Vol. 26, Issue 5, pp. 536-552.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JEIM-07-2013-0045
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:10887-10888
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:7997-7998
Publikováno v:
The American journal of emergency medicine. 36(11)
Autor:
Ei Moe Phyu, Anita Sultan, Thura Win Htut, Sriman Swarup, Nyein Htway Yu, Myat Min Han, Bradley J. Grant, Kyaw Zin Thein, Nimesh Adhikari, Myint Aung Win, Nicholas D'Cunha, Yin Mon Myat, Chandler Graf, Donald P. Quick
Publikováno v:
Blood. 134:5877-5877
Introduction: Chronic lymphocytic leukemia is the most prevalent adult leukemia in western countries. Phosphatidylinositol 3-kinase (PI3K) is a kinase protein involved in downstream signaling for the B-cell receptor signaling pathway and has been sho
Autor:
Thura Win Htut, Somedeb Ball, Myat Min Han, Ei Moe Phyu, Myint Aung Win, Anita Sultan, Donald P. Quick, Nicholas D'Cunha, Lukman Tijani, Kyaw Zin Thein, Ramesh Kumar Pandey, Aung M. Tun, Sriman Swarup, Fred Hardwicke
Publikováno v:
Blood. 134:3158-3158
Introduction: Management of newly diagnosed multiple myeloma (NDMM), which accounts for 1% of all cancers, is an area in dire need of therapeutic innovation. In recent years, the introduction of novel agents is one of the major advances in the manage
Autor:
Ei Moe Phyu, Kyaw Zin Thein, Lukman Tijani, Yin Mon Myat, Donald P. Quick, Myint Aung Win, Nicholas D'Cunha, Sriman Swarup, Nimesh Adhikari, Anita Sultan, Thura Win Htut, Akshar Dash, Myat Min Han, Sanjay Awasthi
Publikováno v:
Blood. 134:1873-1873
Introduction: Multiple myeloma, which accounts for 1% of all cancers, is a hematologic cancer in which clonal plasma-cell proliferation leads to complications and death. Over the recent years, it has shown that the introduction of novel agents, inclu
Autor:
Myat Min Han, Yin Mon Myat, Ye Aung, Anita Sultan, Jonathan Kopel, Akshar Dash, Lukman Tijani, Thura Win Htut, Kyaw Zin Thein, Myint Aung Win, Nicholas D'Cunha, Donald P. Quick, Ei Moe Phyu, Sriman Swarup
Publikováno v:
Blood. 134:5489-5489
Introduction: Idelalisib is a first-in-class potent, oral, selective small-molecule inhibitor of δ isoform of phosphatidylinositol 3-kinase (PI3Kδ), which involves in the signaling of B-cell receptor pathways via activation of downstream serine thr
Autor:
Myint Aung Win, Sriman Swarup, Thura Win Htut, Nicholas D'Cunha, Yin Mon Myat, Ei Moe Phyu, Somedeb Ball, Nyein Htway Yu, Anita Sultan, Donald P. Quick, Kyaw Zin Thein, Myat Min Han, Fred Hardwicke, Sanjay Awasthi
Publikováno v:
Blood. 134:5550-5550
Introduction: Proteasome inhibitors-based regimens are the mainstay of initial therapy for most patients with multiple myeloma. Daratumumab is a human IgGκ monoclonal antibody that targets CD38 with direct antitumor effects and has an immunomodulato
Autor:
Thura Win Htut, Sariya Wongsaengsak, Yin Mon Myat, Donald P. Quick, Ei Moe Phyu, Lukman Tijani, Anita Sultan, Sriman Swarup, Kyaw Zin Thein, Myint Aung Win, Myat Min Han, Sanjay Awasthi, Myet Mon Mon Zin
Publikováno v:
Blood. 134:798-798
Introduction: Phosphatidylinositol 3-kinase (PI3K) is a kinase protein involved in downstream signaling for multiple pathways in B cells and is important for B cell survival, proliferation and metabolism. Hence, PI3K inhibitors have become an attract